Korean J Urol Oncol.  2022 Nov;20(4):265-272. 10.22465/kjuo.2022.20.4.265.

A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association

Affiliations
  • 1Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea
  • 2Department of Urology, Gachon University Gil Medical Center, Incheon, Korea
  • 3Department of Urology, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
  • 4Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea
  • 5Department of Urology, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea
  • 6Department of Urology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
  • 7Department of Urology, Chonnam National University Medical School, Gwangju, Korea
  • 8Department of Urology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea
  • 9Enzaim Health, Seoul, Korea
  • 10Department of Urology, Seoul National University College of Medicine, Seoul, Korea

Abstract

Purpose
We aimed to collect opinions on the diagnostic experiences and quality of life profiles for men with prostate cancer in Korea as part of the “Blue Ribbon Campaign” of the Korean Urological Oncology Society.
Materials and Methods
Korean Urological Oncology Society conducted an online survey of 212 prostate cancer patients belonging to the Prostate Cancer Patient Association. A survey on diagnostic experience and quality of life based on Expanded Prostate Cancer Index Composite 26 Short Form were conducted.
Results
About half of all respondents (50.5%) answered, “I experienced symptoms of urine leakage more than once a week,” during the last four weeks, 85% of the respondents said their sexual function level was “weak,” and 64.2% said, “very weak.” When asked about the level of erectile dysfunction, 58 percent of the respondents answered, “I never had an erection when I wanted one.” Of the respondents, 47.1% of men said that clinical stage at initial presentation was prostate cancer stage 3–4 and 99.1% of the respondents hoped that the prostate-specific antigen (PSA) test would be included in the national cancer screening.
Conclusions
Through this survey of patients, we were able to confirm the difficulties of the low quality of life currently experienced by prostate cancer patients and what they want to do with prostate cancer treatment. All patients are eager to include a PSA test in the national cancer screening so that prostate cancer can be detected early and patients can receive proper treatment at an appropriate time.

Keyword

Prostate cancer; Quality of life; Screening
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr